검색어 : 통합검색[Carreras José]
총 229건 중 229건 출력
, 7/23 페이지
-
61
-
Np9, a cellular protein of retroviral ancestry restricted to human, chimpanzee and gorilla, binds and regulates ubiquitin ligase MDM2
-
Heyne, Kristina;
Kö
lsch, Kathrin;
Bruand, Marine;
Kremmer, Elisabeth;
Grä
sser, Friedrich A;
Mayer, Jens;
Roemer, Klaus;
José
Carreras Center and Internal Medicine I;
University of Saarland Medical Center;
Homburg, Germany;
José
Carreras Center and Internal Medicine I;
University of Saarland Medical Center;
Homburg, Germany;
Institute of Virology;
University of Saarland Medical Center;
Homburg, Germany;
Helmholtz Center;
Institute for Molecular Immunology;
Munich, Germany;
Institute of Virology;
University of Saarland Medical Center;
Homburg, Germany;
Institute of Human Genetics;
Center of Human and Molecular Biology;
Medical Faculty;
University of Saarland;
Homburg, Germany;
José
Carreras Center and Internal Medicine I;
University of Saarland Medical Center;
Homburg, Germany;
(Cell cycle,
v.14,
2015,
pp.2619-2633)
-
62
-
Long-term follow up of patients with human immunodeficiency virus infection and advanced stage Hodgkin's lymphoma treated with doxorubicin, bleomycin, vinblastine and dacarbazine
-
Xicoy, Blanca;
Miralles, Pilar;
Morgades, Mireia;
Rubio, Rafael;
Valencia, Marí
a-Eulalia;
Ribera, Josep-Maria;
;
(Haematologica,
v.98,
2013,
pp.e85-e86)
-
63
-
Targeting the epigenome: effects of epigenetic treatment strategies on genomic stability in healthy human cells
-
Purrucker, Jan C.;
Mahlknecht, Ulrich;
Division of Immunotherapy and Gene Therapy, José
Carreras Center for Immunotherapy and Gene Therapy, Department of Internal Medicine, Saarland University Medical Center, 66421 Homburg/Saar, Germany;
Division of Immunotherapy and Gene Therapy, José
Carreras Center for Immunotherapy and Gene Therapy, Department of Internal Medicine, Saarland University Medical Center, 66421 Homburg/Saar, Germany;
(Clinical epigenetics,
v.1,
2010,
pp.45-54)
-
64
-
Sequential Regimen of Chemotherapy, Reduced-Intensity Conditioning for Allogeneic Stem-Cell Transplantation, and Prophylactic Donor Lymphocyte Transfusion in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome
-
Schmid, Christoph;
Schleuning, Michael;
Ledderose, Georg;
Tischer, Johanna;
Kolb, Hans-Jochem;
From the José
Carreras Unit for Hematopoietic Stem Cell Transplantation, Department of Medicine III, Ludwig-Maximilians-University Hospital, Munich;
and the Stem Cell Transplantation Unit, Deutsche Klinik fü
r Diagnostik, Wiesbaden, Germany;
From the José
Carreras Unit for Hematopoietic Stem Cell Transplantation, Department of Medicine III, Ludwig-Maximilians-University Hospital, Munich;
and the Stem Cell Transplantation Unit, Deutsche Klinik fü
r Diagnostik, Wiesbaden, Germany;
From the José
Carreras Unit for Hematopoietic Stem Cell Transplantation, Department of Medicine III, Ludwig-Maximilians-University Hospital, Munich;
and the Stem Cell Transplantation Unit, Deutsche Klinik fü
r Diagnostik, Wiesbaden, Germany;
From the José
Carreras Unit for Hematopoietic Stem Cell Transplantation, Department of Medicine III, Ludwig-Maximilians-University Hospital, Munich;
and the Stem Cell Transplantation Unit, Deutsche Klinik fü
r Diagnostik, Wiesb;
(Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
v.23,
2005,
pp.5675-5687)
-
65
-
Patterns of infection and infection-related mortality in patients with steroid-refractory acute graft versus host disease
-
Garcí
a-Cadenas, I;
Rivera, I;
Martino, R;
Esquirol, A;
Barba, P;
Novelli, S;
Orti, G;
Briones, J;
Brunet, S;
Valcarcel, D;
Sierra, J;
Hematology Department, Hospital de la Santa Creu i Sant Pau, José
Carreras Leukemia Research Institute and IIB Sant Pau, Universitat Autò
noma de Barcelona, Barcelona, Spain;
Hematology Department, Hospital Vall d’Hebró
n, Universitat Autò
noma de Barcelona, Barcelona, Spain;
Hematology Department, Hospital de la Santa Creu i Sant Pau, José
Carreras Leukemia Research Institute and IIB Sant Pau, Universitat Autò
noma de Barcelona, Barcelona, Spain;
Hematology Department, Hospital de la Santa Creu i Sant Pau, José
Carreras Leukemia Research Institute and IIB Sant Pau, Universitat Autò
noma de Barcelona, Barcelona, Spain;
Hematology Department, Hospital Vall d’Hebró
n, Universitat Autò
noma de Barcelona, Barcelona, Spain;
Hematology Department, Hospital de la Santa Creu i Sant Pau, José
Carreras Leukemia Research Institute and IIB Sant Pau, Universitat Autò
noma de Barcelona, Barcelona, Spain;
Hematology;
(Bone marrow transplantation,
v.52,
2017,
pp.107-113)
-
66
-
Lymphocyte predominant cells detect <i>Moraxella catarrhalis</i> -derived antigens in nodular lymphocyte-predominant Hodgkin lymphoma
-
Thurner, Lorenz;
Hartmann, Sylvia;
Fadle, Natalie;
Regitz, Evi;
Kemele, Maria;
Kim, Yoo-Jin;
Bohle, Rainer Maria;
Nimmesgern, Anna;
von Mü
ller, Lutz;
Kempf, Volkhard A. J.;
Weniger, Marc A.;
Neumann, Frank;
Schneider, Nadine;
Vornanen, Martine;
Sundströ
m, Christer;
de Leval, Laurence;
Engert, Andreas;
Eichenauer, Dennis A.;
Kü
ppers, Ralf;
Preuss, Klaus-Dieter;
Hansmann, Martin-Leo;
Pfreundschuh, Michael;
José
Carreras Center for Immuno- and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany;
Dr. Senckenberg Institute of Pathology, Goethe University, Frankfurt am Main, Germany;
José
Carreras Center for Immuno- and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany;
José
Carreras Center for Immuno- and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany;
José
Carreras Center for Immuno- and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany;
Saarland University Medical School, Institute of Pathology, Homburg/Saar, Germany;
Saarland University Medical School, Institute of Pathology, Homburg/Saar, Germany;
Institute of Medical Microbiology and Hygiene, University of Saarland, Homburg, Germany;
German National Reference Center for Clostridoides (Clostridium) difficile, Institute;
(Nature communications,
v.11,
2020,
pp.2465)
-
67
-
The sirtuins in the pathogenesis of cancer
-
Voelter-Mahlknecht, Susanne;
Mahlknecht, Ulrich;
Department of Internal Medicine, Division of Immunotherapy and Gene Therapy, José
Carreras Center for Immunotherapy and Gene Therapy, Saarland University Medical Center, 66421 Homburg, Saarland Germany;
Department of Internal Medicine, Division of Immunotherapy and Gene Therapy, José
Carreras Center for Immunotherapy and Gene Therapy, Saarland University Medical Center, 66421 Homburg, Saarland Germany;
(Clinical epigenetics,
v.1,
2010,
pp.71-83)
-
68
-
Indeterminate Dendritic Cell Tumor With Persistent Complete Metabolic Response to BRAF/MEK Inhibition
-
Thurner, Lorenz;
Bewarder, Moritz;
Rosar, Florian;
Orth, Patrick;
Meuter, Raoul Boris;
Rixecker, Torben;
Lesan, Vadim;
Kohn, Dieter Michael;
Schneider, Gü
nther;
Baumhoer, Daniel;
Bohle, Rainer Maria;
Veith, Christian;
Bittenbring, Joerg Thomas;
José
Carreras Center for Immuno- and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg, Germany;
José
Carreras Center for Immuno- and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg, Germany;
Institute of Nuclear Medicine, Saarland University Medical School, Homburg, Germany;
Department of Orthopedics, Saarland University Medical School, Homburg, Germany;
Hopitaux Robert Schuman, Chimiothé
rapie, Oncologie, Hé
matologie, Luxembourg;
José
Carreras Center for Immuno- and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg, Germany;
José
Carreras Center for Immuno- and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg, Germany;
Department of Orthopedics, Saarland University Medical School, Homburg, Germany;
Department of Radiology, Saarland University Medical School, Homburg, Germany;
Bone Tumor Reference Center at;
(Hemasphere : Open access journal of the european hematology association,
v.5,
2021,
pp.e511)
-
69
-
Transcriptional repressor NIR interacts with the p53-inhibiting ubiquitin ligase MDM2
-
Heyne, Kristina;
Fö
rster, Juliane;
Schü
le, Roland;
Roemer, Klaus;
José
Carreras Research Center and Internal Medicine I, University of Saarland Medical Center, 66421 Homburg/Saar, Germany and Department of Urology, Center for Clinical Research, University of Freiburg, 79106 Freiburg, Germany;
José
Carreras Research Center and Internal Medicine I, University of Saarland Medical Center, 66421 Homburg/Saar, Germany and Department of Urology, Center for Clinical Research, University of Freiburg, 79106 Freiburg, Germany;
José
Carreras Research Center and Internal Medicine I, University of Saarland Medical Center, 66421 Homburg/Saar, Germany and Department of Urology, Center for Clinical Research, University of Freiburg, 79106 Freiburg, Germany;
José
Carreras Research Center and Internal Medicine I, University of Saarland Medical Center, 66421 Homburg/Saar, Germany and Department of Urology, Center for Clinical Research, University of Freiburg, 79106 Freiburg, Germany;
(Nucleic acids research,
v.42,
2014,
pp.3565-3579)
-
70
-
Incidence and inheritance of hyperphosphorylated paratarg-7 in patients with Waldenstrom’s macroglobulinaemia in Sweden
-
Brandefors, Lena;
Lindh, Jack;
Preuss, Klaus-Dieter;
Fadle, Natalie;
Pfreundschuh, Michael;
Kimby, Eva;
Department of Radiation Sciences, Oncology, Sunderby Research Unit, Umeå
University, Umeå
, Sweden;
;
Department of Radiation Sciences, Oncology, Sunderby Research Unit, Umeå
University, Umeå
, Sweden;
;
José
-Carreras-Center for Immuno- and Gene Therapy, Department of Internal Medicine I, Saarland University Medical School, Homburg, Germany;
;
José
-Carreras-Center for Immuno- and Gene Therapy, Department of Internal Medicine I, Saarland University Medical School, Homburg, Germany;
;
José
-Carreras-Center for Immuno- and Gene Therapy, Department of Internal Medicine I, Saarland University Medical School, Homburg, Germany;
;
Department of Hematology, Karolinska Institute, Stockholm, Sweden;
(Acta oncologica,
v.58,
2019,
pp.824-827)